Brief: Endurance Says European Commercial Partner Got Approval From European Medicines Agency On 15 Sept

Regent Pacific

06/03/2023 13:34

March 6 (Reuters) - Endurance RP Ltd  0575.HK :
    * EUROPEAN COMMERCIAL PARTNER GOT APPROVAL FROM EUROPEAN
MEDICINES
AGENCY ON 15 SEPT TO ADD ALTERNATIVE EUROPEAN MANUFACTURER TO
DOSSIER
    * EXPECT SALES WILL ALSO CONTINUE IN OTHER KEY EUROPEAN
MARKETS AS
SUPPLY IS RESUMED OVER COURSE OF 2023
    * EUROPEAN COMMERCIAL PARTNER RECEIVED FIRST TWO COMMERCIAL
BATCHES OF FORTACIN IN FEB 2023 FOR SALE IN GERMANY AND ITALY
    * EUROPEAN COMMERCIAL PARTNER EXPECTS TO RECEIVE APPROVAL
FROM
MHRA FOR FORTACINTM DOSSIER BY END OF Q1 2023

Source text for Eikon:  ID:nHKS5QxC2K 
Further company coverage:  0575.HK